Donor administration of PAF antagonist (TCV-309) enhances lung preservation
Ide, S.; Kawahara, K.; Takahashi, T.; Sasaki, N.; Shingu, H.; Nagayasu, T.; Yamamoto, S.; Tagawa, T.; Tomita, M.
Transplantation Proceedings 27(1): 570-573
1995
ISSN/ISBN: 0041-1345 PMID: 7879103 Document Number: 446919
Document emailed within 1 workday
Related Documents
Schueler, S.; De Valeria, P.A.; Hatanaka, M.; Cameron, D.E.; Bando, K.; Zeebley, M.; Hutchins, G.M.; Reitz, B.A.; Baumgartner, W.A. 1992: Successful twenty-four-hour lung preservation with donor core cooling and leukocyte depletion in an orthotopic double lung transplantation model Journal of Thoracic and Cardiovascular Surgery 104(1): 73-82Will, B.M.; Wahlers, T.; Fehrenbach, H.; Hirt, S.W.; Haverich, A.; Richter, J. 1995: Human lung preservation with Euro-Collins solution: early postoperative transplant function correlates with ultrastructural alterations of the contralateral donor lung Transplantation Proceedings 27(3): 1997-1999
Senoo, Y.; Bando, K.; Tago, M.; Seno, S.; Teraoka, H.; Teramoto, S. 1990: Extended hypothermic heart-lung preservation system for cardiopulmonary preservation with retrograde coronary sinus perfusion and lung immersion Nihon Kyobu Geka Gakkai 38(9): 1453-1458
Myburgh, J.A.; Smit, J.A. 1972: Hepatic allotransplantation in the baboon. IV. Further studies with the post-transplant administration of donor bone marrow and a soluble donor splenic antigen Transplantation 14(2): 191-199
Kobakhidze, E.A.; Kazakov, E.N.; Allaberdyev, I.; Bogonatov, V.N. 1986: Prolonged (20-24 hours) preservation of donor hearts Vestnik Akademii Meditsinskikh Nauk SSSR 2: 89-94
Ijzermans, J.N.; Bouwman, E.; Jeekel, J.; Marquet, R.L. 1990: Donor pretreatment with IFN-gamma enhances MHC class Ii antigen expression and accelerates graft rejection by modified recipients Transplantation Proceedings 22(4): 1941-1942
Urabe, N.; Fujisawa, T.; Saitoh, Y.; Takeda, T.; Sekine, Y.; Yamaguchi, Y.; Kimizuka, G.; Terano, T. 1994: The capacity of dog lung to release prostaglandin I2 as a biochemical parameter for evaluating lung damage during preservation Transplantation 57(2): 194-198
Pageaux, G.P.; Perrigault, P.F.; Navarro, F.; Blanc, P.; Noel, P.; Quenet, F.; Maurel, P.; Larrey, D.; Michel, H. 1995: Donor liver glutathion S-transferase activity during graft preservation Transplantation Proceedings 27(2): 1656-1657
Ploeg, R.J.; D'Alessandro, A.M.; Hoffmann, R.M.; Eckhoff, D.; Isaacs, R.; Knechtle, S.J.; Pirsch, J.D.; Stegall, M.D.; Kalayoglu, M.; Belzer, F.O. 1993: Impact of donor factors and preservation on function and survival after liver transplantation Transplantation Proceedings 25(6): 3031-3033
Salerno, C.T.; Burdine, J.; Perry, E.H.; Kshettry, V.R.; Hertz, M.I.; Bolman, R.M. 1998: Donor-derived antibodies and hemolysis after ABO-compatible but nonidentical heart-lung and lung transplantation Transplantation 65(2): 261-264
Toyooka, S.; Waki, N.; Okazaki, M.; Kato, K.; Yamane, M.; Oto, T.; Sano, Y.; Date, H. 2009: Recurrent lung cancer in the mediastinum noticed after a living-donor lobar lung transplantation Annals of Thoracic and Cardiovascular Surgery: Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 15(2): 119-122
Figueras, J.; Busquets, J.; Grande, L.; Jaurrieta, E.; Perez-Ferreiroa, J.; Mir, J.; Margarit, C.; Lopez, P.; Vazquez, J.; Casanova, D.; Bernardos, A.; De-Vicente, E.; Parrilla, P.; Ramon, J.M.; Bou, R. 1996: The deleterious effect of donor high plasma sodium and extended preservation in liver transplantation. A multivariate analysis Transplantation 61(3): 410-413
Palombo, J.D.; Hirschberg, Y.; Pomposelli, J.J.; Blackburn, G.L.; Zeisel, S.H.; Bistrian, B.R. 1989: Decreased loss of liver nucleotides and energy charge during hypothermic preservation by donor pretreatment with glucose--a preliminary report Transplantation Proceedings 21(1 Pt 2): 1299-1300
Dourish, C.T.; O'Neill, M.F.; Schaffer, L.W.; Siegl, P.K.; Iversen, S.D. 1990: The cholecystokinin receptor antagonist devazepide enhances morphine-induced analgesia but not morphine-induced respiratory depression in the squirrel monkey Journal of Pharmacology and Experimental Therapeutics 255(3): 1158-1165
Willis, S.; Allescher, H.D.; Stoschus, B.; Schusdziarra, V.; Classen, M.; Schumpelick, V. 1994: Double blind placebo controlled study on the effect of the nitric oxide donor molsidomin and the 5-HT3 antagonist ondansetron on human esophageal motility Zeitschrift für Gastroenterologie 32(11): 632-636
Tsutsaeva, A.A.; Gol'tsev, A.N.; Drozdova, O.A.; Ostankova, L.V. 1980: Effect of low-temperature preservation on the proliferative activity and topography of the dissemination of donor and cadaveric colony-forming units (CFU) in an irradiated organism Tsitologiia i Genetika 14(6): 25-30
Sureda, A.; Canals, C.; Badell, I.; Nomdedeu, J.; Llácer, M.; Brunet, S.; Sierra, J.; Grañena, A.; Cubells, J.; Domingo-Albós, A. 1992: GM-CSF administration enhances granulocytic recovery in purged autologous bone marrow transplantation for acute lymphoblastic leukemia Progress in Clinical and Biological Research 377: 315-320
Sunamori, M.; Amano, J.; Miyamoto, H.; Shirai, T.; Suzuki, A. 1993: Relative advantages of nondepolarizing solution to depolarizing University of Wisconsin solution in donor heart preservation Transplantation Proceedings 25(1 Pt 2): 1613-1617
Bulych, P.V.; Kosiakov, A.N. 2003: Preoperative patient blood preservation as an alternative to donor blood transfusion during joint endoprosthesis surgery Klinichna Khirurhiia 9: 46-48
Slezák, J.; Tribulová, N. 1975: Morphological changes after simultaneous administration of isoproterenol (ISO) and K+,MG2+-Aspartate (KMg-ASP) as a physiological Ca2+ antagonist Arzneimittel-Forschung 25(6): 918-923